Is Compounding A Practical Opportunity For Your Pharmacy? | Pharmacy CrossRoads

Is Compounding A Practical Opportunity For Yo...

Up next

The Truth About Unexplained Infertility with Nick Dorsey | The Holistic Pharmacy Podcast

Today’s guest and I fundamentally agree on the basic premise of the body’s innate wisdom and capacity to heal, especially when we view it in a broader ecological context. According to him, infertility doesn't mean the body is broken; it's actually making intelligent, adaptive, an ...  Show more

Asembia's Specialty Pharmacy Summit 2026 Rewind | Part 2/6

This is the Pharmacy Podcast Network's ASEMBIA 2026 rewind! We're dedicated to bringing you inside coverage of the pharmacy nation's biggest events with on the street style interviews with keynote speakers, attendees, exhibitors, and recurring guests who make each year special. T ...  Show more

Recommended Episodes

The Future of Personalized Medicine | Shaun Noorian
The Dr. Gabrielle Lyon Show

In this episode of the Dr. Gabrielle Lyon Show, we dive deep into the world of compounding pharmacies and the transformative power of anabolic steroids with special guest Shaun Noorian, founder of Empower Pharmacy, one of the largest compounding pharmacies in the U.S.Join us as S ...  Show more

531: Growing a Medical Practice with Dr. Rao
The How of Business - How to start, run, grow and exit a small business.

How to grow a Medical Practice with Dr. Ramesh Rao.

<span style= "mso-bookmark: _Hlk160446384;">Show Notes Page:</span> <span style="mso-bookmark: _Hlk160446384; ...

  Show more

What Every Medical Student Should Know About Integrative Medicine
Spoonful of Sugar

Have you heard of the specialty of integrative medicine? What is it, and how does an integrative medicine physician care for their patients? In this episode, Ria interviews Dr. Chiti Parikh, who is board certified in integrative medicine and is the executive director of the Integ ...  Show more

FDA ends GLP-1 compounding for semaglutide, tirzepatide
Healthcare Strategies

FDA’s removal of GLP-1 drugs from the shortage list ends supplemental compounding, shifting patient access back to branded semaglutide and tirzepatide. Featuring: Sara Heath, executive editor, Xtelligent Healthcare Alivia Kaylor, senior editor of Pharma Life Sciences, Xtelligent ...  Show more